Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001190725-17-000128
Filing Date
2017-05-19
Accepted
2017-05-19 18:06:14
Documents
1
Period of Report
2017-05-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3737
  Complete submission text file 0001190725-17-000128.txt   5142
Mailing Address C/O SGX PHARMACEUTICALS, INC. 10505 ROSELLE STREET SAN DIEGO CA 92121
Business Address
GREY MICHAEL G (Reporting) CIK: 0001240122 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 17859310

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations